Latest AI and machine learning research in schizophrenia for healthcare professionals.
BACKGROUND: While Parkinson's disease is a low dopamine neurodegenerative disorder, Schizophrenia is considered a high dopamine psychiatric disorder. Pharmacological interventions that are directed to normalize dopamine concentrations in the mid-brain for an extended duration lead to unintended consequences. Parkinson's disease patients experience psychosis, and Schizophrenia patients develop extr...
One of the areas where artificial intelligence (AI) technologies are used is the detection and diagnosis of mental disorders. AI approaches, including machine learning and deep learning models, can identify early signs of bipolar disorder, schizophrenia, autism spectrum disorder, depression, suicidality, and dementia by analyzing speech patterns, behaviors, and physiological data. These approaches...
. Functional network connectivity (FNC) estimated from resting-state functional magnetic resonance imaging showed great information about the neural m...
AIM: Prediction of future psychosis in individuals with obsessive and compulsive (OC) symptoms is crucial for treatment choice, but only a few predict...
The study of biological age prediction using various biological data has been widely explored. However, single biological data may offer limited insig...
Identifying predictors of treatment response to repetitive transcranial magnetic stimulation (rTMS) remain elusive in treatment-resistant depression (...
Social interactions are essential for the survival of individuals and the reproduction of populations. Social stressors, such as social defeat and iso...
Understanding reasons for treatment switching is of significant medical interest, but these factors are often only found in unstructured clinical note...
BACKGROUND: Early identification of Schizophrenia Spectrum Disorder (SSD) is crucial for effective intervention and prognosis improvement. Previous ne...
Schizophrenia (SZ) and bipolar disorder (BD) pose diagnostic challenges due to overlapping clinical symptoms and genetic factors, often resulting in m...
There is a notable need of quantifiable and objective methods for the classification of schizophrenia. Patients with schizophrenia exhibit atypical ey...
Measuring medication discontinuation in claims data primarily relies on the gaps between prescription fills, but such definitions are rarely validated...
Magnetic resonance imaging (MRI) is a non-invasive imaging technique that provides high soft tissue contrast, playing a vital role in disease diagnosi...
BACKGROUND: Schizophrenia (SCH) is a complex neurodevelopmental disorder, whose pathogenesis is not fully elucidated. This article aims to reveal dise...
Schizophrenia is a complicated mental condition marked by disruptions in thought processes, perceptions, and emotional responses, which can cause seve...
Clozapine is widely regarded as one of the most effective therapeutics for treatment-resistant schizophrenia. Despite its proven efficacy, the therape...
BACKGROUND: Recently, there have been active proposals on how to utilize large language models (LLMs) in the fields of psychiatry and counseling. It w...
Schizophrenia (SZ) is a complex mental disorder characterized by a profound disruption in cognition and emotion, often resulting in a distorted percep...
The last decade has witnessed a notable surge in deep learning applications for electroencephalography (EEG) data analysis, showing promising improvem...
Diagnostic practices for schizophrenia are unreliable due to the lack of a stable biomarker. However, machine learning holds promise in aiding in the ...